FOXQ1 antibody (full length)

Catalog No. ABIN7878253

The Mouse Monoclonal anti-FOXQ1 antibody (Clone PCRP-FOXQ1-2D2) (ABIN7878253) specifically detects FOXQ1 in ELISA, WB and FACS. The antibody is reactive with Human samples.

Quick Overview for FOXQ1 antibody (full length) (ABIN7878253)

Target: FOXQ1 (Forkhead Box Q1 (FOXQ1))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FOXQ1 antibody is un-conjugated

Application: ELISA, Western Blotting (WB), Flow Cytometry (FACS)

Clone: PCRP-FOXQ1-2D2

Product Details anti-FOXQ1 Antibody

Binding Specificity: full length

Purpose: FOXQ1 Antibody

Purification: Protein A/G affinity

Immunogen: Recombinant full-length human FOXQ1 protein was used as the immunogen for the FOXQ1 antibody.

Isotype: IgG1

Application Details

Application Notes: Optimal dilution of the FOXQ1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the FOXQ1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for FOXQ1

Target: FOXQ1 (Forkhead Box Q1 (FOXQ1))

Alternative Name: FOXQ1

Background: DNA replication is initiated by the binding of initiation factors to the origin of replication. Nucleosomes inhibit access to the replication machinery at these origin sequences. Nucleosome remodeling factors increase the accessibility of nucleosomal DNA to transcriptional regulators. CHRAC15 and CHRAC17 are subunits of the nucleosomal remodeling factor CHRAC (chromatin accessibility complex), which increases the accessibility of nucleosomal DNA in an ATP-dependent manner. Unlike other known chromatin remodeling factors, CHRAC also functions during chromatin assembly by using ATP to convert irregular chromatin into a regular array of nucleosomes with even spacing. This conversion process occurs when CHRAC organizes randomly deposited histones into a regularly spaced array. In the presence of CHRAC, the nucleosomal ATPase ISWI catalyzes several ATP-dependent transitions of chromatin structure.

UniProt: Q9C009

Pathways: Positive Regulation of Endopeptidase Activity